Neurovascular In-Stent Stenoses: Treatment with Conventional and Drug-Eluting Balloons

References

1. 1.↵
   1. Levy EI,
   2. Turk AS,
   3. Albuquerque FC,
   4. et al

   . Wingspan in-stent restenosis and thrombosis: incidence, clinical presentation, and management. Neurosurgery 2007;61:644–50

   CrossRefPubMedWeb of Science
2. 2.↵
   1. Chimowitz MI,
   2. Lynn MJ,
   3. Howlett-Smith H,
   4. et al

   . Comparison of warfarin and aspirin for symptomatic intracranial arterial stenosis. N Engl J Med 2005;352:1305–16

   CrossRefPubMedWeb of Science
3. 3.↵
   Failure of extracranial-intracranial arterial bypass to reduce the risk of ischemic stroke: results of an international randomized trial—the EC/IC Bypass Study Group. N Engl J Med 1985;313:1191–200

   CrossRefPubMedWeb of Science
4. 4.↵
   1. Sundt TM Jr.,
   2. Smith HC,
   3. Campbell JK,
   4. et al

   . Transluminal angioplasty for basilar artery stenosis. Mayo Clin Proc 1980;55:673–80

   PubMedWeb of Science
5. 5.↵
   1. Marks MP,
   2. Wojak JC,
   3. Al-Ali F,
   4. et al

   . Angioplasty for symptomatic intracranial stenosis: clinical outcome. Stroke 2006;37:1016–20

   Abstract/FREE Full Text
6. 6.↵
   1. Berg-Dammer E,
   2. Henkes H,
   3. Weber W,
   4. et al

   . Percutaneous transluminal angioplasty of intracranial artery stenosis: clinical results in 24 patients. Neurosurg Focus 1998;5:e13

   PubMed
7. 7.↵
   1. Vajda Z,
   2. Miloslavski E,
   3. Güthe T,
   4. et al

   . Treatment of intracranial atherosclerotic arterial stenoses with a balloon-expandable cobalt chromium stent (Coroflex Blue): procedural safety, efficacy, and midterm patency. Neuroradiology 2010;52:645–51. Epub 2009 Nov 17

   CrossRefPubMedWeb of Science
8. 8.↵
   1. Gupta R,
   2. Al-Ali F,
   3. Thomas AJ,
   4. et al

   . Safety, feasibility, and short-term follow-up of drug-eluting stent placement in the intracranial and extracranial circulation. Stroke 2006;37:2562–66

   Abstract/FREE Full Text
9. 9.↵
   1. Mocco J,
   2. Darkhabani Z,
   3. Levy EI

   . Pharos neurovascular intracranial stent: elective use for a symptomatic stenosis refractory to medical therapy. Catheter Cardiovasc Interv 2009;74:642–46

   CrossRefPubMed
10. 10.↵
    1. Henkes H,
    2. Miloslavski E,
    3. Lowens S,
    4. et al

    . Treatment of intracranial atherosclerotic stenoses with balloon dilatation and self-expanding stent deployment (Wingspan). Neuroradiology 2005;47:222–28. Epub 2005 Mar 15

    CrossRefPubMedWeb of Science
11. 11.↵
    1. Abou-Chebl A,
    2. Bashir Q,
    3. Yadav JS

    . Drug-eluting stents for the treatment of intracranial atherosclerosis: initial experience and midterm angiographic follow-up. Stroke 2005;36:e165–68

    Abstract/FREE Full Text
12. 12.↵
    1. Gröschel K,
    2. Schnaudigel S,
    3. Pilgram SM,
    4. et al

    . A systematic review on outcome after stenting for intracranial atherosclerosis. Stroke 2009;40:e340–47

    Abstract/FREE Full Text
13. 13.↵
    1. Turk AS,
    2. Levy EI,
    3. Albuquerque FC,
    4. et al

    . Influence of patient age and stenosis location on Wingspan in-stent restenosis. AJNR Am J Neuroradiol 2008;29:23–27

    Abstract/FREE Full Text
14. 14.↵
    1. Vajda Z,
    2. Schmid E,
    3. Güthe T,
    4. et al

    . The modified Bose-method for the endovascular treatment of intracranial atherosclerotic arterial stenoses using the Enterprise stent. Neurosurgery 2011 July 19.
15. 15.↵
    1. Scott NA

    . Restenosis following implantation of bare metal coronary stents: pathophysiology and pathways involved in the vascular response to injury. Adv Drug Deliv Rev 2006;58:358–76

    CrossRefPubMedWeb of Science
16. 16.↵
    1. Güthe T,
    2. Miloslavski E,
    3. Vajda Z,
    4. et al

    . Recurrent in-stent restenosis in a symptomatic non-atherosclerotic M1 plaque: successful treatment with paclitaxel-eluting balloon dilatation after repeated failure of conventional balloon reangioplasty. Clin Neuroradiol 2010;20:165–69. Epub 2010 May 29

    CrossRefPubMed
17. 17.↵
    1. Scheller B,
    2. Speck U,
    3. Abramjuk C,
    4. et al

    . Paclitaxel balloon coating, a novel method for prevention and therapy of restenosis. Circulation 2004;110:810–14. Epub 2004 Aug 9

    Abstract/FREE Full Text
18. 18.↵
    1. Scheller B,
    2. Hehrlein C,
    3. Bocksch W,
    4. et al

    . Two year follow-up after treatment of coronary in-stent restenosis with a paclitaxel-coated balloon catheter. Clin Res Cardiol 2008;97:773–81

    CrossRefPubMedWeb of Science
19. 19.↵
    1. Tepe G,
    2. Zeller T,
    3. Albrecht T,
    4. et al

    . Local delivery of paclitaxel to inhibit restenosis during angioplasty of the leg. N Engl J Med 2008;358:689–99

    CrossRefPubMedWeb of Science
20. 20.↵
    1. Samuels OB,
    2. Joseph GJ,
    3. Lynn MJ,
    4. et al

    . A standardized method for measuring intracranial arterial stenosis. AJNR Am J Neuroradiol 2000;21:643–46

    Abstract/FREE Full Text
21. 21.↵
    1. Apisarnthanarax S,
    2. Chougule P

    . Intravascular brachytherapy: a review of the current vascular biology. Am J Clin Oncol 2003;26:e13–21

    PubMed
22. 22.↵
    1. Daemen J,
    2. Serruys PW

    . Drug-eluting stent update 2007. Part II. Unsettled issues. Circulation 2007;116:961–68

    FREE Full Text
23. 23.↵
    1. Schachner T,
    2. Steger C,
    3. Heiss S,
    4. et al

    . Paclitaxel treatment reduces neointimal hyperplasia in cultured human saphenous veins. Eur J Cardiothorac Surg 2007;32:906–11

    Abstract/FREE Full Text